Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.02 EUR
298.90 M EUR
3.36 B EUR
9.64 B
About SINO BIOPHARMACEUTICAL
Sector
CEO
S Y Tse
Headquarters
Hong Kong
Website
Founded
2000
FIGI
BBG000CBMMY1
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SMZ1 is 0.41 EUR — it has increased by 4.22% in the past 24 hours. Watch SINO BIOPHARMACEUTICAL LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SINO BIOPHARMACEUTICAL LTD stocks are traded under the ticker SMZ1.
SMZ1 stock has fallen by −0.31% compared to the previous week, the month change is a −4.23% fall, over the last year SINO BIOPHARMACEUTICAL LTD has showed a −7.55% decrease.
We've gathered analysts' opinions on SINO BIOPHARMACEUTICAL LTD future price: according to them, SMZ1 price has a max estimate of 0.84 EUR and a min estimate of 0.35 EUR. Watch SMZ1 chart and read a more detailed SINO BIOPHARMACEUTICAL LTD stock forecast: see what analysts think of SINO BIOPHARMACEUTICAL LTD and suggest that you do with its stocks.
SMZ1 reached its all-time high on Jul 23, 2020 with the price of 1.29 EUR, and its all-time low was 0.00148146 EUR and was reached on Feb 26, 2009. View more price dynamics on SMZ1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SMZ1 stock is 4.30% volatile and has beta coefficient of 1.28. Track SINO BIOPHARMACEUTICAL LTD stock price on the chart and check out the list of the most volatile stocks — is SINO BIOPHARMACEUTICAL LTD there?
Today SINO BIOPHARMACEUTICAL LTD has the market capitalization of 7.55 B, it has decreased by −1.14% over the last week.
Yes, you can track SINO BIOPHARMACEUTICAL LTD financials in yearly and quarterly reports right on TradingView.
SINO BIOPHARMACEUTICAL LTD is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
SMZ1 earnings for the last half-year are 0.01 EUR per share, whereas the estimation was 0.01 EUR, resulting in a 9.43% surprise. The estimated earnings for the next half-year are 0.01 EUR per share. See more details about SINO BIOPHARMACEUTICAL LTD earnings.
SINO BIOPHARMACEUTICAL LTD revenue for the last half-year amounts to 2.04 B EUR, despite the estimated figure of 1.95 B EUR. In the next half-year revenue is expected to reach 1.99 B EUR.
SMZ1 net income for the last half-year is 186.90 M EUR, while the previous report showed 134.48 M EUR of net income which accounts for 38.98% change. Track more SINO BIOPHARMACEUTICAL LTD financial stats to get the full picture.
SINO BIOPHARMACEUTICAL LTD dividend yield was 1.44% in 2023, and payout ratio reached 35.95%. The year before the numbers were 2.63% and 75.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 13, 2024, the company has 25.81 K employees. See our rating of the largest employees — is SINO BIOPHARMACEUTICAL LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINO BIOPHARMACEUTICAL LTD EBITDA is 910.02 M EUR, and current EBITDA margin is 25.87%. See more stats in SINO BIOPHARMACEUTICAL LTD financial statements.
Like other stocks, SMZ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINO BIOPHARMACEUTICAL LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINO BIOPHARMACEUTICAL LTD technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINO BIOPHARMACEUTICAL LTD stock shows the neutral signal. See more of SINO BIOPHARMACEUTICAL LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.